Can EndoFLIP Improve Quality of Life Before and After Fundoplication?

NCT ID: NCT06159972

Last Updated: 2023-12-07

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-01-05
• Study Completion Date: 2024-12-31

Brief Summary

Patients with reflux disease (heart burn), or a hiatal hernia, who do not get better with medication, may have surgery to help with their symptoms. Unfortunately, there is no agreed upon way to perform the surgery. The investigators are using a new surgical instrument called the EndoFLIP which allows surgeons to take measurements during the operation. The investigators will compare the measurements obtained during surgery with a quality of life score that we will calculate from a questionnaire.

Detailed Description

Gastroesophageal reflux disease (GERD) has a prevalence of 30% in North America (Richter 2018), where patients can present with reflux, heartburn, dysphagia, chest pain, or a combination of symptoms. Those referred by their primary care physician to a specialist have often already failed a trial of proton pump inhibitors (PPI), thus warranting further investigation. Practice guidelines from the American College of Gastroenterologists (Katz 2013) recommend that patients undergo upper endoscopy, followed by esophageal manometry, and reflux monitoring before any surgical intervention.

While these recommendations are well-founded, patient compliance with these tests remains low, since esophageal manometry and 24-hour pH testing are generally poorly tolerated, involving the placement of probes inserted nasogastrically. A qualitative study investigated patient perceptions of 24-hour pH monitoring and manometry testing (Walamies 2002) and asked 92 patients to describe their experience with manometry. Of the 84 respondents, 52% reported moderate-severe discomfort. It was shown that many patients are fearful and anxious about these tests. Some may refuse them due to their invasiveness, especially if having already undergone endoscopic evaluation. Undergoing surgery with an indeterminate diagnosis or in the absence of a full motility assessment is contraindicated by current practice guidelines and devastating consequences could occur. The lack of preoperative investigations could omit a large subset of potential surgical candidates or even lead to anti-reflux surgery in patients for the wrong diagnosis.

Once a patient is considered a surgical candidate, operative management aims to reestablish the anti-reflux barrier by plicating the gastric fundus around the gastroesophageal junction (GEJ), called fundoplication. Until now, there is no established objective measure to determine how tight to make the fundoplication. Some surgeons use a bougie to estimate the diameter of the GEJ (Patterson 2000), while some use an endoscope, and others rely on their subjective judgement. A fundoplication that is too narrow can cause severe postoperative dysphagia symptoms, whereas one that is too loose may cause recurrence or worsening of GERD symptoms. A balance is required.

The EndoFLIP balloon catheter allows users to measure the cross-sectional area (CSA), diameter, pressure and distensibility index (DI) of the GEJ. This can be done intraoperatively to obtain objective measures of the tightness of the fundoplication. These results may then be correlated with post-operative symptoms to determine the optimal CSA and DI in fundoplication. Previous studies have sought to address this problem but were limited by their lack of standardized EndoFLIP use (Su 2019). Symptom severity measurements were also captured too early in the post-operative period before a new baseline was established (Nwokedi 2020). This proposed study will have a defined EndoFLIP protocol that will be used to obtain all measurements. In addition, our post-operative readings will be captured no earlier than four months from the date of surgery. The investigators attempt to establish objective measurements to guide future operative interventions, thereby improving postoperative symptoms and overall patient satisfaction.

During the pre-operative workup, most patients with a clinical indication for 24-hour pH monitoring and manometry testing will undergo an esophagogastroduodenoscopy (EGD). This is much better tolerated, allowing for the administration of topical anesthetic and intravenous sedating medications. EndoFLIP readings can be taken at the time of EGD, thereby decreasing the number of investigations that may prolong preoperative workup. Clinicians may be able to rely on these readings alone in select patients.

Prior studies investigating the use of this novel technique have compared preoperative and post-operative CSA and DI values following a wide range of esophagogastric procedures [Attaar 2021, Ichkhanian 2020] and others have established a relationship with patient reported outcomes [Su 2020, Nwokedi 2020]. Some have compared CSA and DI in patients with and without achalasia [Carlson 2015]. Others have attempted to identify a correlation between EndoFLIP readings and anorectal manometry [Zifan 2018, Leroi 2018], and with pyloric manometry [Snape 2016]. One group of investigators [Tucker 2013] attempted to validate EndoFLIP readings with acid exposure time on pH testing and found no correlation between the two. That study was limited by its small sample size and the retrospective nature of the data, resulting in uncontrolled confounding. A true correlation between EndoFLIP measurements with 24-hour pH monitoring and esophageal manometry has yet to be identified.

To summarise, a knowledge of the intra-operative EndoFLIP measurements that correlate with acceptable post-operative symptom severity scores will be useful information for surgeons performing a fundoplication (there currently is no gold standard for fundoplication creation). Secondly, if pre-operative EndoFLIP measurements correlate well with pre-operative 24-hr pH studies and manometry testing, then there is a potential for EndoFLIP to replace these invasive, uncomfortable, and poorly tolerated tests. This may result in increased patient compliance and reduced costs of pre-operative testing.

Conditions

GERD; Hiatal Hernia

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

EndoFLIP

Intraop EndoFLIP measurements

Group Type: EXPERIMENTAL

EndoFLIP

Intervention Type: DEVICE

EndoFLIP is a small balloon catheter that is inserted through the endoscope at the time of endoscopy.

Interventions

EndoFLIP

EndoFLIP is a small balloon catheter that is inserted through the endoscope at the time of endoscopy.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Adult patients undergoing workup for gastroesophageal reflux disease (GERD) and/or symptomatic hiatal hernia who undergo fundoplication AND who undergo fundoplication

Exclusion Criteria

• Those with a previous history of hiatal hernia repair, fundoplication, esophagectomy, or gastrectomy
• Inability to provide consent

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Medtronic

INDUSTRY

Sponsor Role: collaborator

Dr. Wiley Chung

OTHER

Sponsor Role: lead

Responsible Party

Dr. Wiley Chung

Thoracic Surgeon and Assistant Professor

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Wiley Chung, MD MHPE

Role: PRINCIPAL_INVESTIGATOR

Queen's University

Locations

KHSC

Kingston, Ontario, Canada

Site Status: RECRUITING

Countries

Canada

Central Contacts

Nader M Hanna, MBBS, MSc

Role: CONTACT

Phone: (613) 549-6666

Email: nader.hanna@queensu.ca

Facility Contacts

Wiley Chung, MD, MHPE

Role: primary

Other Identifiers

6035362

Identifier Type: -

Identifier Source: org_study_id